Flow Cytometers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Flow Cytometers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Flow Cytometers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Flow cytometers are an electronic detection apparatus used in a technique for counting and examining microscopic particles, such as cells and chromosomes, by suspending them in a stream of fluid.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Flow Cytometers under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Flow Cytometers and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Flow Cytometers under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Flow Cytometers Overview
4 Products under Development
4.1 Flow Cytometers - Pipeline Products by Stage of Development
4.2 Flow Cytometers - Pipeline Products by Territory
4.3 Flow Cytometers - Pipeline Products by Regulatory Path
4.4 Flow Cytometers - Pipeline Products by Estimated Approval Date
4.5 Flow Cytometers - Ongoing Clinical Trials
5 Flow Cytometers - Pipeline Products under Development by Companies
5.1 Flow Cytometers Companies - Pipeline Products by Stage of Development
5.2 Flow Cytometers – Companies Pipeline Products by Stage of Development
7.3 Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
7.4 Aug 23, 2023: BD to Present at Investor Healthcare Conferences
7.5 May 26, 2023: Novacyt Announces Publication of Annual Report and AGM voting
7.6 May 18, 2023: BD launches World's first spectral cell sorter with high-speed cell imaging
7.7 Apr 20, 2023: Cytek Biosciences to report Q1 2023 financial results on May 9, 2023
7.8 Apr 18, 2023: Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer
7.9 Mar 07, 2023: Cytek Biosciences introduces new 20-Color AML panel
7.1 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
7.11 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
7.12 Feb 07, 2023: Cytek Biosciences partners with Bio-Rad to expand reagent portfolios
7.13 Feb 07, 2023: Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
7.14 Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
7.15 Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report
7.16 Nov 10, 2022: Novacyt Announces David Allmond is stepping down as Chief Executive Officer
7.17 Nov 09, 2022: Cytek Biosciences Reports Third Quarter 2022 Financial Results
7.18 Oct 31, 2022: Cytek Biosciences Names Chris Williams Chief Operating Officer
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Flow Cytometers - Pipeline Products by Stage of Development
Table 2: Flow Cytometers - Pipeline Products by Territory
Table 3: Flow Cytometers - Pipeline Products by Regulatory Path
Table 4: Flow Cytometers - Pipeline Products by Estimated Approval Date